What is Cercle?
Cercle operates a sophisticated software platform, the Cercle Biomedical Graph. This innovative system is designed to ingest and transform de-identified healthcare data into real-time, high-quality insights. Women's healthcare providers leverage these insights to enhance the efficiency of their businesses and deliver more personalized patient care. The company's focus on actionable data analytics positions it as a key player in modernizing healthcare operations.
How much funding has Cercle raised?
Cercle has raised a total of $6M across 1 funding round:
Angel/Seed
$6M
Angel/Seed (2024): $6M with participation from Outsiders Fund and FemHealth Ventures
Key Investors in Cercle
Outsiders Fund
Outsiders Fund is an early-stage venture capital firm that supports founders with unique perspectives aiming to disrupt outdated industries. The firm focuses on seed and Series A investments, primarily in the United States and Canada, with check sizes ranging from $500K to $8M.
FemHealth Ventures
FemHealth Ventures is a venture capital firm focused on investing in women's health, specifically targeting conditions that affect only women, mostly women, and those that manifest differently in women. The firm aims to transform women's health by harnessing proven science to develop groundbreaking health solutions while achieving exceptional financial returns.
What's next for Cercle?
With a major enterprise-level funding context and a recent strategic investment, Cercle is poised for significant expansion. The company is likely to focus on scaling its platform's reach, enhancing its data processing capabilities, and potentially forging new partnerships within the women's healthcare ecosystem. This strategic backing suggests a trajectory towards solidifying its market position and further developing its unique data-driven solutions to address critical needs in healthcare delivery.
See full Cercle company page
